These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The patient at risk: who should we be treating? Shviro I, Leitersdorf E. Br J Clin Pract Suppl; 1996 Jan; 77A():24-7. PubMed ID: 8729587 [Abstract] [Full Text] [Related]
8. [Statins in primary prevention of coronary heart disease]. Paulweber B. Wien Med Wochenschr; 1999 Jan; 149(5-6):129-38. PubMed ID: 10408004 [Abstract] [Full Text] [Related]
9. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP. Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154 [Abstract] [Full Text] [Related]
20. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM. Am J Cardiol; 2009 Feb 01; 103(3):369-74. PubMed ID: 19166691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]